ReP USP - Resultado da busca

Artigo de periodico
Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass (2021)
Silva, Carlos Gustavo dos Santos ; Nigro Neto, Caetano ; Hirata, Mario Hiroyuki ; Tardelli, Maria Angela; Bastos, Gisele Medeiros ; França, Joao Italo Dias ; Cardoso, Thiago Augusto Azevedo Maranhão
Source: Journal of Cardiothoracic and Vascular Anesthesia. Unidades: IDPC, FCF, FSP
Subjects: REVASCULARIZAÇÃO MIOCÁRDICA, ANESTÉSICOS, CIRCULAÇÃO EXTRACORPÓREA, ANESTESIA GERAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Carlos Gustavo dos Santos et al. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, v. 35, n. 8, p. 2447-2453, 2021Tradução . . Disponível em: https://doi.org/10.1053/j.jvca.2020.12.032. Acesso em: 26 jun. 2024.
APA
Silva, C. G. dos S., Nigro Neto, C., Hirata, M. H., Tardelli, M. A., Bastos, G. M., França, J. I. D., & Cardoso, T. A. A. M. (2021). Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass. Journal of Cardiothoracic and Vascular Anesthesia, 35( 8), 2447-2453. doi:10.1053/j.jvca.2020.12.032
NLM
Silva CG dos S, Nigro Neto C, Hirata MH, Tardelli MA, Bastos GM, França JID, Cardoso TAAM. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass [Internet]. Journal of Cardiothoracic and Vascular Anesthesia. 2021 ; 35( 8): 2447-2453.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1053/j.jvca.2020.12.032
Vancouver
Silva CG dos S, Nigro Neto C, Hirata MH, Tardelli MA, Bastos GM, França JID, Cardoso TAAM. Minimum alveolar concentration of sevoflurane as a single hypnotic agent to maintain BIS below 50 in patients during normothermic cardiopulmonary bypass [Internet]. Journal of Cardiothoracic and Vascular Anesthesia. 2021 ; 35( 8): 2447-2453.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1053/j.jvca.2020.12.032
Artigo de periodico
Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol (2021)
Borges, Jéssica Bassani ; Oliveira, Victor Fernandes de ; Ferreira, Glaucio Monteiro ; Los, Bruna; Barbosa, Thais Kristini Almendros Afonso; Marçal, Elisangela da Silva Rodrigues; Hernandez, Carolina Dagli; Freitas, Renata Caroline Costa de ; Bortolin, Raul Hernandes ; Mori, Augusto Akira ; Hirata, Thiago Dominguez Crespo ; Nakaya, Helder Takashi Imoto ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Gonçalves, Rodrigo Marques; Araújo, Daniel Branco de; Zatz, Henry Paulo; Bertolami, Adriana; Faludi, André Arpad; Bertolami, Marcelo Chiara ; Sousa, Amanda Guerra de Moraes Rego ; França, Joao Italo Dias ; Jannes, Cinthia Elim; Pereira, Alexandre da Costa; Nakazone, Marcelo Arruda; Souza, Dorotéia Rossi Silva; Carmo, Tayanne Silva; Sampaio, Marcelo Ferraz; Gorjão, Renata ; Curi, Tania Cristina Pithon ; Moriel, Patricia; Silbiger, Vivian Nogueira ; Luchessi, André Ducati ; Araújo, Jéssica Nayara Góes de; Naslavsky, Michel ; Wang, Jaqueline Yu Ting; Kronenberger, Thales ; Cerda, Alvaro ; Wang, Hui Tzu Lin; Garofalo, Adriana Regina; Fajardo, Cristina Moreno ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Research in Social and Administrative Pharmacy. Unidades: FCF, IDPC, FM, IB
Subjects: GENÔMICA, HIPERCOLESTEROLEMIA, FARMACOGENÉTICA, EXONS, LINFÓCITOS, LINHAGEM CELULAR, MUTAGÊNESE, SEQUENCIAMENTO GENÉTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Jéssica Bassani et al. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, v. 17, n. 7, p. 1347-1355, 2021Tradução . . Disponível em: https://doi.org/10.1016/j.sapharm.2020.10.007. Acesso em: 26 jun. 2024.
APA
Borges, J. B., Oliveira, V. F. de, Ferreira, G. M., Los, B., Barbosa, T. K. A. A., Marçal, E. da S. R., et al. (2021). Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol. Research in Social and Administrative Pharmacy, 17( 7), 1347-1355. doi:10.1016/j.sapharm.2020.10.007
NLM
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Vancouver
Borges JB, Oliveira VF de, Ferreira GM, Los B, Barbosa TKAA, Marçal E da SR, Hernandez CD, Freitas RCC de, Bortolin RH, Mori AA, Hirata TDC, Nakaya HTI, Bastos GM, Thurow HS, Gonçalves RM, Araújo DB de, Zatz HP, Bertolami A, Faludi AA, Bertolami MC, Sousa AG de MR, França JID, Jannes CE, Pereira A da C, Nakazone MA, Souza DRS, Carmo TS, Sampaio MF, Gorjão R, Curi TCP, Moriel P, Silbiger VN, Luchessi AD, Araújo JNG de, Naslavsky M, Wang JYT, Kronenberger T, Cerda A, Wang HTL, Garofalo AR, Fajardo CM, Hirata RDC, Hirata MH. Genomics, epigenomics and pharmacogenomics of familial hypercholesterolemia (FHBGEP): a study protocol [Internet]. Research in Social and Administrative Pharmacy. 2021 ; 17( 7): 1347-1355.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1016/j.sapharm.2020.10.007
Artigo de periodico
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome (2021)
Braga, Aécio Assunção ; Bortolin, Raul Hernandes ; Saldarriaga, Magda Elizabeth Graciano ; Hirata, Thiago Dominguez Crespo ; Cerda, Alvaro; Freitas, Renata Caroline Costa de ; Wang, Hui Tzu Lin ; Borges, Jessica B; França, Joao Italo Dias ; Masi, Laureane Nunes ; Curi, Rui ; Curi, Tania Cristina Phiton ; Sampaio, Marcelo Ferraz; Castro, Lara R; Bastos, Gisele Medeiros ; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki
Source: Epigenomics. Unidade: FCF
Subjects: ADIPOSIDADE, SÍNDROME X METABÓLICA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRAGA, Aécio Assunção et al. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, v. 13, n. 6 p. 423–436, 2021Tradução . . Disponível em: https://doi.org/10.2217/epi-2020-0247. Acesso em: 26 jun. 2024.
APA
Braga, A. A., Bortolin, R. H., Saldarriaga, M. E. G., Hirata, T. D. C., Cerda, A., Freitas, R. C. C. de, et al. (2021). High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome. Epigenomics, 13( 6 p. 423–436). doi:10.2217/epi-2020-0247
NLM
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jun. 26 ] Available from: https://doi.org/10.2217/epi-2020-0247
Vancouver
Braga AA, Bortolin RH, Saldarriaga MEG, Hirata TDC, Cerda A, Freitas RCC de, Wang HTL, Borges JB, França JID, Masi LN, Curi R, Curi TCP, Sampaio MF, Castro LR, Bastos GM, Hirata RDC, Hirata MH. High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome [Internet]. Epigenomics. 2021 ; 13( 6 p. 423–436):[citado 2024 jun. 26 ] Available from: https://doi.org/10.2217/epi-2020-0247
Artigo de periodico
Increased levels of plasma IL-1b and BDNF can predict resistant depression patients (2019)
Uint, Luciana ; Bastos, Gisele Medeiros ; Thurow, Helena Strelow ; Borges, Jéssica Bassani ; Hirata, Thiago Dominguez Crespo ; França, Joao Italo Dias ; Hirata, Mario Hiroyuki ; Sousa, Amanda Guerra de Moraes Rego
Source: Revista da Associação Medica Brasileira. Unidade: FCF
Subjects: TRANSTORNO BIPOLAR, DEPRESSÃO, INFLAMAÇÃO, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
UINT, Luciana et al. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients. Revista da Associação Medica Brasileira, v. 65, n. 3, p. 361-369, 2019Tradução . . Disponível em: https://doi.org/10.1590/1806-9282.65.3.361. Acesso em: 26 jun. 2024.
APA
Uint, L., Bastos, G. M., Thurow, H. S., Borges, J. B., Hirata, T. D. C., França, J. I. D., et al. (2019). Increased levels of plasma IL-1b and BDNF can predict resistant depression patients. Revista da Associação Medica Brasileira, 65( 3), 361-369. doi:10.1590/1806-9282.65.3.361
NLM
Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AG de MR. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients [Internet]. Revista da Associação Medica Brasileira. 2019 ; 65( 3): 361-369.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1590/1806-9282.65.3.361
Vancouver
Uint L, Bastos GM, Thurow HS, Borges JB, Hirata TDC, França JID, Hirata MH, Sousa AG de MR. Increased levels of plasma IL-1b and BDNF can predict resistant depression patients [Internet]. Revista da Associação Medica Brasileira. 2019 ; 65( 3): 361-369.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1590/1806-9282.65.3.361
Artigo de periodico
Intragraft vasculitis and gene expression analysis: association with acute rejection and prediction of mortality in long-term heart transplantation (2018)
Wang, Hui-Tzu Lin; Cipullo, Reginaldo; França, Joao Italo Dias; Finger, Marco Aurelio; Rossi Neto, João Manoel; Correia, Edileide de Barros; Dinkhuysen, Jarbas Jackson; Hirata, Mario Hiroyuki
Source: Clinical Transplantation. Unidade: FCF
Subjects: VASCULITE, EXPRESSÃO GÊNICA, TRANSPLANTE DE CORAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WANG, Hui-Tzu Lin et al. Intragraft vasculitis and gene expression analysis: association with acute rejection and prediction of mortality in long-term heart transplantation. Clinical Transplantation, v. 32, n. 10, p. 1-10 art. e13373, 2018Tradução . . Disponível em: https://doi.org/10.1111/ctr.13373. Acesso em: 26 jun. 2024.
APA
Wang, H. -T. L., Cipullo, R., França, J. I. D., Finger, M. A., Rossi Neto, J. M., Correia, E. de B., et al. (2018). Intragraft vasculitis and gene expression analysis: association with acute rejection and prediction of mortality in long-term heart transplantation. Clinical Transplantation, 32( 10), 1-10 art. e13373. doi:10.1111/ctr.13373
NLM
Wang H-TL, Cipullo R, França JID, Finger MA, Rossi Neto JM, Correia E de B, Dinkhuysen JJ, Hirata MH. Intragraft vasculitis and gene expression analysis: association with acute rejection and prediction of mortality in long-term heart transplantation [Internet]. Clinical Transplantation. 2018 ; 32( 10): 1-10 art. e13373.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1111/ctr.13373
Vancouver
Wang H-TL, Cipullo R, França JID, Finger MA, Rossi Neto JM, Correia E de B, Dinkhuysen JJ, Hirata MH. Intragraft vasculitis and gene expression analysis: association with acute rejection and prediction of mortality in long-term heart transplantation [Internet]. Clinical Transplantation. 2018 ; 32( 10): 1-10 art. e13373.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1111/ctr.13373
Artigo de periodico
Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls (2011)
Hayashi, Silvia Yoko; Faintuch, Joel; França, Joao Italo Dias; Cecconello, Ivan
Source: Obesity surgery. Unidade: FM
Subjects: CIRURGIA BARIÁTRICA, OBESIDADE MÓRBIDA (CIRURGIA;COMPLICAÇÕES), COMORBIDADE, SEGUIMENTOS, DERIVAÇÃO JEJUNO-ILEAL, CUIDADOS PRÉ-OPERATÓRIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HAYASHI, Silvia Yoko et al. Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls. Obesity surgery, v. 21, n. 9, p. 1355\20131361, 2011Tradução . . Disponível em: https://doi.org/10.1007/s11695-011-0404-3. Acesso em: 26 jun. 2024.
APA
Hayashi, S. Y., Faintuch, J., França, J. I. D., & Cecconello, I. (2011). Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls. Obesity surgery, 21( 9), 1355\20131361. doi:10.1007/s11695-011-0404-3
NLM
Hayashi SY, Faintuch J, França JID, Cecconello I. Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls [Internet]. Obesity surgery. 2011 ; 21( 9): 1355\20131361.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1007/s11695-011-0404-3
Vancouver
Hayashi SY, Faintuch J, França JID, Cecconello I. Four-year hospital resource utilization after bariatric surgery: comparison with clinical and surgical controls [Internet]. Obesity surgery. 2011 ; 21( 9): 1355\20131361.[citado 2024 jun. 26 ] Available from: https://doi.org/10.1007/s11695-011-0404-3

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Source title

Funding Agencies

Non normalized affiliation